Health
COVID-19 vaccine | UK reserves 190 million doses from Valneva – Moneycontrol
Valneva said it expects to begin trials of the two-dose vaccine in December and if it is successful for it to become available in the second half of 2021.
Britain has secured access to up to 190 million doses of a potential coronavirus vaccine from French-Austrian biotech company Valneva, AFP reported.
The deal between the UK and Valnevaworth as much as 1.37 billion euros, the firm said on September 14.
It had already been disclosed in July that the British government had reserved 60 million doses of Valneva’s inactivated SARS-CoV-2 vaccine under development.
The firm said it expects to begin trials of the two-dose vaccine in December and if it…
-
General13 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News22 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News14 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
General23 hours agoIndigenous excellence honoured in NAIDOC’s 50th year